Harrow, Inc. Business Acquisition, Pro Forma Net Income (Loss)
Harrow, Inc. (HROW) reported Business Acquisition, Pro Forma Net Income (Loss) of -$3.09 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2015-11-12
- Harrow, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2015-03-31 was -$3.09M.
- Harrow, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2014-12-31 was -$2.90M.
- Harrow, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2014-09-30 was -$2.35M.
- Harrow, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2014-06-30 was -$2.67M.
- Harrow, Inc. business acquisition, pro forma net income (loss) for fiscal 2014 was -$10.05M.
- Harrow, Inc. business acquisition, pro forma net income (loss) for fiscal 2013 was -$7.08M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 3 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month as first filed | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|---|---|---|
| 2015-03-31 | -$3.09M 10-Q · filed 2015-05-13 | -$5.99M derived: sum of 2 quarters · filed 2015-05-13 | -$8.34M derived: sum of 3 quarters · filed 2015-11-12 | -$11.01M derived: sum of 4 quarters · filed 2015-11-12 | |||
| 2014-12-31 | -$2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$5.25M derived: sum of 2 quarters · filed 2015-11-12 | -$7.92M derived: sum of 3 quarters · filed 2015-11-12 | -$10.05M 10-K · filed 2015-03-12 | |||
| 2014-09-30 | -$2.35M 10-Q · filed 2015-11-12 | -$2.45M 10-Q · filed 2014-11-12 | -$5.02M derived: sum of 2 quarters · filed 2015-11-12 | -$7.15M 10-Q · filed 2015-11-12 | -$7.28M 10-Q · filed 2014-11-12 | -$9.00M derived: sum of 4 quarters · filed 2015-11-12 | |
| 2014-06-30 | -$2.67M 10-Q · filed 2015-08-12 | -$2.60M 10-Q · filed 2014-08-13 | -$4.85M 10-Q · filed 2015-08-12 | -$4.85M 10-Q · filed 2014-08-13 | -$6.65M derived: sum of 3 quarters · filed 2015-08-12 | -$8.59M derived: sum of 4 quarters · filed 2015-08-12 | |
| 2014-03-31 | -$2.18M 10-Q · filed 2015-05-13 | -$3.98M derived: sum of 2 quarters · filed 2015-05-13 | -$5.92M derived: sum of 3 quarters · filed 2015-05-13 | -$7.98M derived: sum of 4 quarters · filed 2015-05-13 | |||
| 2013-12-31 | -$1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$3.74M derived: sum of 2 quarters · filed 2015-03-12 | -$5.80M derived: sum of 3 quarters · filed 2015-03-12 | -$7.08M 10-K · filed 2015-03-12 | |||
| 2013-09-30 | -$1.94M 10-Q · filed 2014-11-12 | -$3.99M derived: sum of 2 quarters · filed 2014-11-12 | -$5.28M 10-Q · filed 2014-11-12 | ||||
| 2013-06-30 | -$2.05M 10-Q · filed 2014-08-13 | -$3.37M 10-Q · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |